Search the Newsreel

NeoGenomics announces planned departure of General Counsel Alicia Olivo

NeoGenomics, Inc. announced that Alicia Olivo, Executive Vice President, General Counsel, and Business Development, will depart from her role as General Counsel effective September 21, 2026, and will assist with the transition until October 2, 2026. This news follows the company's strong second-quarter 2026 …

ServiceNow (NOW) CEO McDermott logs RSU vesting, tax share withholding and trust holdings

ServiceNow (NOW) Chairman & CEO William R. McDermott reported recent RSU vesting and related transactions. On August 7, 2026, he exercised 8,765 RSUs into common stock, with 4,712 shares withheld for tax obligations. Following these transactions, McDermott directly holds 8,775 restricted stock units and …

ServiceNow (NOW) HR chief settles 2,630 RSUs, withholds 1,343 shares for taxes

ServiceNow's Chief People & AI Enablement Officer, Jacqueline P. Canney, settled 2,630 Restricted Stock Units (RSUs) on August 7, 2026. In connection with this, 1,343 shares were withheld at $124.88 per share to cover tax obligations. Following these transactions, Canney directly holds 2,635 RSUs …

ServiceNow (NOW) president Amit Zavery exercises RSUs, withholds 5,370 shares for taxes

ServiceNow President Amit Zavery exercised 9,990 Restricted Stock Units (RSUs) on August 7, 2026, receiving an equal number of common stock shares. To cover tax obligations, 5,370 shares were withheld at a price of $124.88 per share. Following this transaction, Zavery holds 9,995 RSUs …

ServiceNow (NOW) CFO Mastantuono exercises RSUs, withholds shares for tax payment

ServiceNow's President and CFO, Gina Mastantuono, reported the vesting and exercise of 3,945 restricted stock units (RSUs) into common stock on August 7, 2026. To cover tax obligations, 2,121 shares were withheld at a price of $124.88 per share. Following this transaction, Mastantuono retains …

Lenovo (SEHK:992) Stock Looks Reasonable By Sector Yet Stretched On Earnings

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Lenovo Group's share price has surged over the past few years, yet its current valuation checks point to a stock that screens as overvalued on …

Operating margin % of Enova International Inc – HAM:27E

This article displays the operating margin percentage for Enova International Inc (HAM:27E) on TradingView. It provides a brief overview of the company's financial data on the Hamburg Stock Exchange. The content is primarily a data placeholder within a financial platform's interface.

GCM Grosvenor Inc. (NASDAQ:GCMG) Receives Average Rating of "Moderate Buy" from Analysts

Revenue per share of Enova International Inc – HAM:27E

The article focuses on the "Revenue per share" metric for Enova International Inc (HAM:27E) on the Hamburg Stock Exchange. It appears to be a financial data page from TradingView, providing an overview of the company's financial performance.

GCM Grosvenor (NASDAQ:GCMG) Price Target Raised to $13.00 at JPMorgan Chase & Co.

Can Enovis (ENOV) Narrowing Losses Without Strong Sales Growth Sustain Its Long-Term Strategy?

Enovis Corporation (ENOV) reported Q2 2026 sales of US$582.78 million, a modest increase year-over-year, and significantly reduced its net loss to US$1.19 million from US$36.74 million. The company reaffirmed its 2026 revenue guidance of US$2.31 billion to US$2.37 billion, indicating management's confidence despite only …

GCM Grosvenor (NASDAQ:GCMG) Hits New 52-Week High on Better-Than-Expected Earnings

RenovoRx completes enrollment in phase III pancreatic cancer trial

RenovoRx (NASDAQ:RNXT) has completed enrollment in its Phase III TIGeR-PaC trial for locally advanced pancreatic cancer, with patient enrollment closing on August 7th. The company anticipates trial completion by the first half of 2027, with initial topline data expected in the second half of …

Lenovo's Overbought Rally Meets Its Moment of Truth as Earnings Land This Week

Metagenomi Records Wider Q2 Loss As MGX-001 Advanced Toward IND Submission

(RTTNews) - Metagenomi Therapeutics Inc. (MGX), an in vivo genome editing company, on Monday reported second quarter financial results, noting a higher loss owing to increased losses from operations and collaborations. The company specializes in in metagenomics - the study of genetic material from …

(KEN) Movement as an Input in Quant Signal Sets

This article analyzes Kenon Holdings Ltd. (NYSE: KEN) using AI-generated quantitative signals, indicating weak near and mid-term sentiment despite a positive long-term outlook. It outlines institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report highlights …

RenovoRx pancreatic cancer trial closes enrollment; 78 deaths occurred

RenovoRx announced the full enrollment of its Phase III

Wells Fargo cuts Metagenomi stock price target on higher R&D costs

Wells Fargo has lowered its price target for Metagenomi Inc (NASDAQ:MGX) shares to $7.00 from $9.00, while maintaining an Overweight rating, citing higher-than-expected research and development expenses and a larger net loss per share in Q2 2026. Despite the stock trading down 24% year-to-date, …

EXCLUSIVE: Renovorx Advances Its Targeted Pancreatic Cancer Therapy, Pivotal Data Expected in 2027

RenovoRx, Inc. (NASDAQ: RNXT) has completed patient enrollment for its Phase 3 TIGeR-PaC study for locally advanced pancreatic cancer (LAPC), utilizing its RenovoCath targeted drug delivery platform. The study, which compares intra-arterial gemcitabine (IAG) against standard systemic chemotherapy, is expected to conclude in the …

H.C. Wainwright reiterates Xenon Pharmaceuticals stock rating at buy

H.C. Wainwright maintained a Buy rating and a $74.00 price target for Xenon Pharmaceuticals (NASDAQ: XENE), citing the FDA's lack of concerns regarding their pre-NDA meeting and the company's belief that their drug package supports approval of all four doses. The stock has seen …

HC Wainwright Issues Positive Outlook for XENE Earnings

HC Wainwright has revised its earnings outlook for Xenon Pharmaceuticals (NASDAQ:XENE), predicting reduced losses for Q3 2026 and subsequent fiscal years, and maintaining a "Buy" rating with a $74 price target. The biopharmaceutical company recently surpassed analyst expectations for its quarterly loss. Despite these …

Handelsbanken Fonder AB Has $86.51 Million Stock Holdings in ServiceNow, Inc. $NOW

Handelsbanken Fonder AB reduced its stake in ServiceNow, Inc. by 4.7% in the second quarter, now holding 871,356 shares valued at $86.51 million. Other institutional investors like Vanguard Group Inc., State Street Corp, Price T Rowe Associates Inc. MD, Geode Capital Management LLC, and …

Amphenol (APH) After Its Dividend Update And The Case For A Full Valuation

Citizens reiterates ServiceNow stock rating on federal contract wins By Investing.com

Citizens has maintained its Market Outperform rating and $157 price target for ServiceNow (NYSE:NOW) shares, citing four federal contract awards exceeding $10 million in Q3 2026. Despite a 14% year-to-date decline, the stock has shown recent upward momentum. InvestingPro analysis suggests the stock is …

ServiceNow, Inc. $NOW Holdings Boosted by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB significantly increased its stake in ServiceNow, Inc. (NYSE:NOW) by 62.0% in the second quarter, making the stock its 19th largest holding. Several other institutional investors also adjusted their positions in ServiceNow. The company recently reported strong quarterly …

Terreno Realty Corp CFO Jaime Cannon sells $245,872 in stock By Investing.com

Terreno Realty Corp CFO Jaime Cannon sold 3,602 shares of company stock worth $245,872 on August 10, 2026. Following this transaction, Ms. Cannon directly holds 114,787 shares and indirectly owns 73,202 shares through a Rabbi Trust. The company has a market cap of $7.45 …

10x Genomics (TXG): Doubled, Then Doubled Again

10x Genomics (TXG) has been a significant winner for Hedgeye, with its stock price soaring over 157% since May 19 due to strong Signal Strength, favorable macroeconomic "Quads," and robust fundamental performance. The company recently reported strong second-quarter results, raised full-year guidance, and despite …

198,047 Shares in Kenon Holdings Ltd. $KEN Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. acquired 198,047 shares of Kenon Holdings Ltd. ($KEN) in the second quarter, valued at approximately $13.4 million, making them owners of 0.38% of the company. Other institutional investors also adjusted their stakes in Kenon, with a total of 13.38% of …

Terreno Realty president Michael Coke sells $547,040 in shares

Terreno Realty Corp (NASDAQ:TRNO) President and Director Michael A. Coke sold 8,000 shares of the company's common stock for $547,040 on August 7, 2026, at a price of $68.38 per share. Following this transaction, Coke directly holds 425,381 shares and indirectly 204,830 shares. The …

Stronger Q2 Results And Higher 2026 Output Guidance Could Be A Game Changer For Cenovus Energy (TSX:CVE)

Cenovus Energy reported strong Q2 2026 results with increased sales and net income, along with higher upstream production and an upgraded 2026 production guidance. The company also continues a share buyback program and maintains its quarterly dividend. These developments reinforce Cenovus's short-term volume and …

ServiceNow extends the benefits of AI to its Microsoft 365 assets with Microsoft Copilot Studio

ServiceNow has integrated Microsoft Copilot Studio with its existing AI infrastructure to enable employees to create AI agents that connect with Microsoft 365 assets. This initiative led to the development of a Microsoft AI Agent Creation Portal, allowing employees to build various AI solutions, …

Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ...

Bionano Genomics Inc (BNGO) reported Q2 2026 revenue of $8.2 million, a 21% year-over-year increase, exceeding guidance, driven by record flow cell sales. Despite strong demand and increased gross margins, the company faces supply constraints for flow cells and a decline in software revenue. …

Bionano Genomics, Inc. Q2 2026 Earnings Call Summary

Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

RXO, BrightView, SiteOne, ServiceNow, and Rocket Lab Shares Are Soaring, What You Need To Know

RXO, BrightView, SiteOne, ServiceNow, and Rocket Lab Shares Are Soaring, What You Need To Know What Happened? A number of stocks jumped in the afternoon session after the July jobs report showed an unexpected loss of 23,000 jobs, signaling a cooling labor market. Economists …

Bionano Genomics earnings beat by $0.13, revenue topped estimates

Metagenomi Therapeutics reports $27.5M loss in Q2 2026

Metagenomi Therapeutics (NASDAQ: MGX) reported a significant net loss of $27.482 million in Q2 2026, widening from the previous year, and missed analyst EPS estimates. The company's collaboration revenue dropped sharply to $(0.257) million from $8.513 million in Q2 2025. Despite these financial setbacks, …